CD66e/CEA/CEACAM5 Human Monoclonal Antibody
Anti-Human CD66e/CEA/CEACAM5 (BMCD423) is a research-grade recombinant antibody targeting CD66. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen
UniProt
P06731
Reactivity
Human
Clonality
Monoclonal
Clone
BMCD423
Conjugation
Unconjugated
Field of Research
Cancer Biology; Cell Biology
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Major Vault Protein (MVP) (1032), CF405S conjugate, 0.1mg/mL
Complement C4d (C4D204), CF568 conjugate, 0.1mg/mL
P27 / KIP1 (SX53G8), CF488A conjugate, 0.1mg/mL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF594 conjugate, 0.1mg/mL
Human Kappa Light Chain (KLC709), CF568 conjugate, 0.1mg/mL
